19 results on '"Bashiri Dezfouli, Ali"'
Search Results
2. Isothiocyanates in medicine: A comprehensive review on phenylethyl-, allyl-, and benzyl-isothiocyanates
- Author
-
Hoch, Cosima C., Shoykhet, Maria, Weiser, Tobias, Griesbaum, Lena, Petry, Julie, Hachani, Khouloud, Multhoff, Gabriele, Bashiri Dezfouli, Ali, and Wollenberg, Barbara
- Published
- 2024
- Full Text
- View/download PDF
3. 1,8-cineole (eucalyptol): A versatile phytochemical with therapeutic applications across multiple diseases
- Author
-
Hoch, Cosima C., Petry, Julie, Griesbaum, Lena, Weiser, Tobias, Werner, Kathrin, Ploch, Michael, Verschoor, Admar, Multhoff, Gabriele, Bashiri Dezfouli, Ali, and Wollenberg, Barbara
- Published
- 2023
- Full Text
- View/download PDF
4. Elevated circulating Hsp70 levels are correlative for malignancies in different mammalian species
- Author
-
Salvermoser, Lukas, Flisikowski, Krzysztof, Dressel-Böhm, Susann, Nytko, Katarzyna J., Rohrer Bley, Carla, Schnieke, Angelika, Samt, Ann-Kathrin, Thölke, Dennis, Lennartz, Philipp, Schwab, Melissa, Wang, Fei, Bashiri Dezfouli, Ali, and Multhoff, Gabriele
- Published
- 2023
- Full Text
- View/download PDF
5. Optimizing the recovery of peripheral blood mononuclear cells trapped in leukoreduction filters - A comparison study
- Author
-
Bashiri Dezfouli, Ali, Pourfathollah, Ali Akbar, Nikougoftar-Zarif, Mahin, Khosravi, Mohammad, Tajrishi, Mona, Ezzati, Nasim, Kashani Khatib, Zahra, Abbasi Sourki, Parvaneh, and Valizadeh, Maryam
- Published
- 2022
- Full Text
- View/download PDF
6. Significant decrease in the viability and tumor stem cell marker expression in tumor cell lines treated with curcumin
- Author
-
Buhrmann, Constanze, Yazdi, Mina, Bashiri Dezfouli, Ali, Samani Sahraneshin, Fazel, Ebrahimi, Seyed Morteza, Hamidollah Ghaffari, Seyed, Yaghmaie, Marjan, Barin, Abbas, Shakibaei, Mehdi, and Shayan, Parviz
- Published
- 2020
- Full Text
- View/download PDF
7. Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70‐Derived Peptide: A Combined Computational and Experimental Study.
- Author
-
Yazdi, Mina, Hasanzadeh Kafshgari, Morteza, Khademi Moghadam, Fatemeh, Zarezade, Vahid, Oellinger, Rupert, Khosravi, Mohammad, Haas, Stefan, Hoch, Cosima C., Pockley, Alan Graham, Wagner, Ernst, Wollenberg, Barbara, Multhoff, Gabriele, and Bashiri Dezfouli, Ali
- Subjects
CELL receptors ,KILLER cells ,PEPTIDES ,MOLECULAR dynamics ,NATURAL immunity ,INTERLEUKIN receptors ,PEPTIDE receptors - Abstract
Natural killer (NK) cells are central components of the innate immunity system against cancers. Since tumor cells have evolved a series of mechanisms to escape from NK cells, developing methods for increasing the NK cell antitumor activity is of utmost importance. It is previously shown that an ex vivo stimulation of patient‐derived NK cells with interleukin (IL)‐2 and Hsp70‐derived peptide TKD (TKDNNLLGRFELSG, aa450‐461) results in a significant upregulation of activating receptors including CD94 and CD69 which triggers exhausted NK cells to target and kill malignant solid tumors expressing membrane Hsp70 (mHsp70). Considering that TKD binding to an activating receptor is the initial step in the cytolytic signaling cascade of NK cells, herein this interaction is studied by molecular docking and molecular dynamics simulation computational modeling. The in silico results showed a crucial role of the heterodimeric receptor CD94/NKG2A and CD94/NKG2C in the TKD interaction with NK cells. Antibody blocking and CRISPR/Cas9–mediated knockout studies verified the key function of CD94 in the TKD stimulation and activation of NK cells which is characterized by an increased cytotoxic capacity against mHsp70 positive tumor cells via enhanced production and release of lytic granules and pro‐inflammatory cytokines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors.
- Author
-
Hoch, Cosima C., Knoedler, Leonard, Knoedler, Samuel, Bashiri Dezfouli, Ali, Schmidl, Benedikt, Trill, Anskar, Douglas, Jennifer E., Adappa, Nithin D., Stögbauer, Fabian, and Wollenberg, Barbara
- Abstract
Purpose of Review: This review aims to provide a comprehensive overview of mesenchymal sinonasal tract tumors (STTs), a distinct subset of STTs. Despite their rarity, mesenchymal STTs represent a unique clinical challenge, characterized by their rarity, often slow progression, and frequently subtle or overlooked symptoms. The complex anatomy of the sinonasal area, which includes critical structures such as the orbit, brain, and cranial nerves, further complicates surgical treatment options. This underscores an urgent need for more advanced and specialized therapeutic approaches. Recent Findings: Advancements in molecular diagnostics, particularly in next-generation sequencing, have significantly enhanced our understanding of STTs. Consequently, the World Health Organization has updated its tumor classification to better reflect the distinct histological and molecular profiles of these tumors, as well as to categorize mesenchymal STTs with greater accuracy. The growing understanding of the molecular characteristics of mesenchymal STTs opens new possibilities for targeted therapeutic interventions, marking a significant shift in treatment paradigms. Summary: This review article concentrates on mesenchymal STTs, specifically addressing sinonasal tract angiofibroma, sinonasal glomangiopericytoma, biphenotypic sinonasal sarcoma, and skull base chordoma. These entities are marked by unique histopathological and molecular features, which challenge conventional treatment approaches and simultaneously open avenues for novel targeted therapies. Our discussion is geared towards delineating the molecular underpinnings of mesenchymal STTs, with the objective of enhancing therapeutic strategies and addressing the existing shortcomings in the management of these intricate tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. ChatGPT's Response Consistency: A Study on Repeated Queries of Medical Examination Questions.
- Author
-
Funk, Paul F., Hoch, Cosima C., Knoedler, Samuel, Knoedler, Leonard, Cotofana, Sebastian, Sofo, Giuseppe, Bashiri Dezfouli, Ali, Wollenberg, Barbara, Guntinas-Lichius, Orlando, and Alfertshofer, Michael
- Subjects
CHATGPT ,PERIODIC health examinations ,CLINICAL medical education ,ARTIFICIAL intelligence - Abstract
(1) Background: As the field of artificial intelligence (AI) evolves, tools like ChatGPT are increasingly integrated into various domains of medicine, including medical education and research. Given the critical nature of medicine, it is of paramount importance that AI tools offer a high degree of reliability in the information they provide. (2) Methods: A total of n = 450 medical examination questions were manually entered into ChatGPT thrice, each for ChatGPT 3.5 and ChatGPT 4. The responses were collected, and their accuracy and consistency were statistically analyzed throughout the series of entries. (3) Results: ChatGPT 4 displayed a statistically significantly improved accuracy with 85.7% compared to that of 57.7% of ChatGPT 3.5 (p < 0.001). Furthermore, ChatGPT 4 was more consistent, correctly answering 77.8% across all rounds, a significant increase from the 44.9% observed from ChatGPT 3.5 (p < 0.001). (4) Conclusions: The findings underscore the increased accuracy and dependability of ChatGPT 4 in the context of medical education and potential clinical decision making. Nonetheless, the research emphasizes the indispensable nature of human-delivered healthcare and the vital role of continuous assessment in leveraging AI in medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Biomarkers in Adult-Type Diffuse Gliomas: Elevated Levels of Circulating Vesicular Heat Shock Protein 70 Serve as a Biomarker in Grade 4 Glioblastoma and Increase NK Cell Frequencies in Grade 3 Glioma.
- Author
-
Lennartz, Philipp, Thölke, Dennis, Bashiri Dezfouli, Ali, Pilz, Mathias, Lobinger, Dominik, Messner, Verena, Zanth, Hannah, Ainslie, Karen, Kafshgari, Morteza Hasanzadeh, Rammes, Gerhard, Ballmann, Markus, Schlegel, Martin, Foulds, Gemma Ann, Pockley, Alan Graham, Schmidt-Graf, Friederike, and Multhoff, Gabriele
- Subjects
KILLER cells ,HEAT shock proteins ,GLIOMAS ,GLIOBLASTOMA multiforme ,T helper cells ,METHYLGUANINE - Abstract
The presence of circulating Hsp70 levels and their influence on the immunophenotype of circulating lymphocyte subsets were examined as diagnostic/prognostic biomarkers for the overall survival (OS) in patients with IDH-mutant WHO grade 3 oligodendroglioma, astrocytoma, and IDH-wildtype grade 4 glioblastoma (GBM). Vesicular and free Hsp70 in the plasma/serum was measured using the Hsp70-exo and R&D Systems DuoSet
® Hsp70 ELISAs. The immunophenotype and membrane Hsp70 status was determined by multiparameter flow cytometry on peripheral blood lymphocytes and single-cell suspensions of tumor specimens and cultured cells. Compared to healthy controls, circulating vesicular Hsp70 levels were significantly increased in patients with GBM, concomitant with a significant decrease in the proportion of CD3+/CD4+ helper T cells, whereas the frequency of NK cells was most prominently increased in patients with grade 3 gliomas. Elevated circulating Hsp70 levels and a higher prevalence of activated CD3−/CD56+/CD94+/CD69+ NK cells were associated with an improved OS in grade 3 gliomas, whereas high Hsp70 levels and low CD3+/CD4+ frequencies were associated with an adverse OS in GBM. It is assumed that a reduced membrane Hsp70 density on grade 4 versus grade 3 primary glioma cells and reduced CD3+/CD4+ T cell counts in GBM might drive an immunosuppressive tumor microenvironment. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
11. Functionalized Hybrid Iron Oxide–Gold Nanoparticles Targeting Membrane Hsp70 Radiosensitize Triple-Negative Breast Cancer Cells by ROS-Mediated Apoptosis.
- Author
-
Wu, Zhiyuan, Stangl, Stefan, Hernandez-Schnelzer, Alicia, Wang, Fei, Hasanzadeh Kafshgari, Morteza, Bashiri Dezfouli, Ali, and Multhoff, Gabriele
- Subjects
GOLD ,IRON oxide nanoparticles ,APOPTOSIS ,RESEARCH funding ,REACTIVE oxygen species ,CELL lines ,BREAST tumors ,NANOPARTICLES - Abstract
Simple Summary: Breast cancer is the most common cancer in women worldwide, and triple-negative breast cancer (TNBC) is the malignancy with the worst prognosis. Although the vast majority of TNBC patients are treated with multimodal therapies, including ionizing irradiation (IR), as a standard of care, radiation-resistant tumor cells and off-target toxicities preclude an advantageous clinical outcome. We studied the radiosensitizing effect of novel Hsp70-specific, hybrid iron oxide–gold (Fe
3 O4 -Au) nanoparticles (NPs) functionalized with the Hsp70 peptide TPP via a PEG4 linker (TPP-PEG4) to target tumor-specific membrane Hsp70 (mHsp70) on TNBCs. TPP can increase the affinity and uptake of hybrid Fe3 O4 -Au nanoparticles (FeAuNPs) into TNBC cells. TPP-PEG4-FeAuNPs, but not control hybrid FeAuNPs, significantly sensitize TNBC cells against radiation by activating a G2/M checkpoint arrest and elevating the production of reactive oxygen species (ROS), which induce DNA double-strand breaks in TNBC. Triple-negative breast cancer (TNBC) a highly aggressive tumor entity with an unfavorable prognosis, is treated by multimodal therapies, including ionizing radiation (IR). Radiation-resistant tumor cells, as well as induced normal tissue toxicity, contribute to the poor clinical outcome of the disease. In this study, we investigated the potential of novel hybrid iron oxide (Fe3 O4 )-gold (Au) nanoparticles (FeAuNPs) functionalized with the heat shock protein 70 (Hsp70) tumor-penetrating peptide (TPP) and coupled via a PEG4 linker (TPP-PEG4-FeAuNPs) to improve tumor targeting and uptake of NPs and to break radioresistance in TNBC cell lines 4T1 and MDA-MB-231. Hsp70 is overexpressed in the cytosol and abundantly presented on the cell membrane (mHsp70) of highly aggressive tumor cells, including TNBCs, but not on corresponding normal cells, thus providing a tumor-specific target. The Fe3 O4 core of the NPs can serve as a contrast agent enabling magnetic resonance imaging (MRI) of the tumor, and the nanogold shell radiosensitizes tumor cells by the release of secondary electrons (Auger electrons) upon X-ray irradiation. We demonstrated that the accumulation of TPP-PEG4-FeAuNPs into mHsp70-positive TNBC cells was superior to that of non-conjugated FeAuNPs and FeAuNPs functionalized with a non-specific, scrambled peptide (NGL). After a 24 h co-incubation period of 4T1 and MDA-MB-231 cells with TPP-PEG4-FeAuNPs, but not with control hybrid NPs, ionizing irradiation (IR) causes a cell cycle arrest at G2/M and induces DNA double-strand breaks, thus triggering apoptotic cell death. Since the radiosensitizing effect was completely abolished in the presence of the ROS inhibitor N-acetyl-L-cysteine (NAC), we assume that the TPP-PEG4-FeAuNP-induced apoptosis is mediated via an increased production of ROS. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
12. Elevated Levels of Circulating Hsp70 and an Increased Prevalence of CD94+/CD69+ NK Cells Is Predictive for Advanced Stage Non-Small Cell Lung Cancer.
- Author
-
Seier, Sophie, Bashiri Dezfouli, Ali, Lennartz, Philipp, Pockley, Alan Graham, Klein, Henriette, and Multhoff, Gabriele
- Subjects
- *
LUNG cancer diagnosis , *HEAT shock proteins , *TUMOR classification , *TUMOR markers - Abstract
Simple Summary: This study reveals that circulating Hsp70 levels could serve as a tumor biomarker for patients with NSCLC in advanced UICC stages. All patients in advanced tumor stages had significantly elevated Hsp70 levels in the circulation compared to a healthy control cohort and an early-stage tumor cohort, and Hsp70 levels progressively increased with higher UICC tumor stages. These findings demonstrate the potential of Hsp70 measurements to predict an advanced tumor stage in NSCLC patients. We have also demonstrated that the prevalence of CD3−/CD94+ NK cells and CD8+ cytotoxic T cells were greater in advanced tumor stages, whereas that of CD4+ T helper cells was decreased. We hypothesize that raised levels of circulating Hsp70 in higher tumor stages might support NK cell proliferation, but that a lowered prevalence of CD4+ T helper cells could temper the capacity of cytolytic CD8+ T cells and NK cells to control tumor growth. Non-small cell lung cancer (NSCLC) is the second most frequently diagnosed tumor worldwide. Despite the clinical progress which has been achieved by multimodal therapies, including radiochemotherapy, and immune checkpoint inhibitor blockade, the overall survival of patients with advanced-stage NSCLC remains poor, with less than 16 months. It is well established that many aggressive tumor entities, including NSCLC, overexpress the major stress-inducible heat shock protein 70 (Hsp70) in the cytosol, present it on the plasma membrane in a tumor-specific manner, and release Hsp70 into circulation. Although high Hsp70 levels are associated with tumor aggressiveness and therapy resistance, membrane-bound Hsp70 can serve as a tumor-specific antigen for Hsp70-primed natural killer (NK) cells, expressing the C-type lectin receptor CD94, which is part of the activator receptor complex CD94/NKG2C. Therefore, we investigated circulating Hsp70 levels and changes in the composition of peripheral blood lymphocyte subsets as potential biomarkers for the advanced Union for International Cancer Control (UICC) stages in NSCLC. As expected, circulating Hsp70 levels were significantly higher in NSCLC patients compared to the healthy controls, as well as in patients with advanced UICC stages compared to those in UICC stage I. Smoking status did not influence the circulating Hsp70 levels significantly. Concomitantly, the proportions of CD4+ T helper cells were lower compared to the healthy controls and stage I tumor patients, whereas that of CD8+ cytotoxic T cells was progressively higher. The prevalence of CD3−/CD56+, CD3−/NKp30, CD3−/NKp46+, and CD3−/NKG2D+ NK cells was higher in stage IV/IIIB of the disease than in stage IIIA but were not statistically different from that in healthy individuals. However, the proportion of NK cells expressing CD94 and the activation/exhaustion marker CD69 significantly increased in higher tumor stages compared with stage I and the healthy controls. We speculate that although elevated circulating Hsp70 levels might promote the prevalence of CD94+ NK cells in patients with advanced-stage NSCLC, the cytolytic activity of these NK cells also failed to control tumor growth due to insufficient support by pro-inflammatory cytokines from CD4+ T helper cells. This hypothesis is supported by a comparative multiplex cytokine analysis of the blood in lung cancer patients with a low proportion of CD4+ T cells, a high proportion of NK cells, and high Hsp70 levels versus patients with a high proportion of CD4+ T cells exhibiting lower IL-2, IL-4, IL-6, IFN-γ, granzyme B levels. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
- Author
-
Bashiri Dezfouli, Ali, Yazdi, Mina, Benmebarek, Mohamed-Reda, Schwab, Melissa, Michaelides, Stefanos, Miccichè, Arianna, Geerts, Dirk, Stangl, Stefan, Klapproth, Sarah, Wagner, Ernst, Kobold, Sebastian, and Multhoff, Gabriele
- Subjects
KILLER cells ,T cells ,HEAT shock proteins ,CHIMERIC antigen receptors ,PEPTIDES - Abstract
Strategies to boost anti-tumor immunity are urgently needed to treat therapy-resistant late-stage cancers, including colorectal cancers (CRCs). Cytokine stimulation and genetic modifications with chimeric antigen receptors (CAR) represent promising strategies to more specifically redirect anti-tumor activities of effector cells like natural killer (NK) and T cells. However, these approaches are critically dependent on tumor-specific antigens while circumventing the suppressive power of the solid tumor microenvironment and avoiding off-tumor toxicities. Previously, we have shown that the stress-inducible heat shock protein 70 (Hsp70) is frequently and specifically expressed on the cell surface of many different, highly aggressive tumors but not normal tissues. We could take advantage of tumors expressing Hsp70 on their membrane ('mHsp70') to attract and engage NK cells after in vitro stimulation with the 14-mer Hsp70 peptide TKDNNLLGRFELSG (TKD) plus low dose interleukin (IL)-2. However, a potential limitation of activated primary NK cells after adoptive transfer is their comparably short life span. T cells are typically long-lived but do not recognize mHsp70 on tumor cells, even after stimulation with TKD/IL-2. To combine the advantages of mHsp70-specificity with longevity, we constructed a CAR having specificity for mHsp70 and retrovirally transduced it into primary T cells. Co-culture of anti-Hsp70 CAR-transduced T cells with mHsp70-positive tumor cells stimulates their functional responsiveness. Herein, we demonstrated that human CRCs with a high mHsp70 expression similarly attract TKD/IL-2 stimulated NK cells and anti-Hsp70 CAR T cells, triggering the release of their lytic effector protein granzyme B (GrB) and the pro-inflammatory cytokine interferon (IFN)-γ, after 4 and 24 hours, respectively. In sum, stimulated NK cells and anti-Hsp70 CAR T cells demonstrated comparable anti-tumor effects, albeit with somewhat differing kinetics. These findings, together with the fact that mHsp70 is expressed on a large variety of different cancer entities, highlight the potential of TKD/IL-2 pre-stimulated NK, as well as anti-Hsp70 CAR T cells to provide a promising direction in the field of targeted, cell-based immunotherapies which can address significant unmet clinical needs in a wide range of cancer settings. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Evaluating Total Mercury and Methyl Mercury Contents in Canned Tuna Fish of the Persian Gulf
- Author
-
Bashiri Dezfouli, Ali, Salar-Amoli, Jamileh, Ali-Esfahani, Tahereh, Hosseini, Hedayat, and Ghanati, Kiandokht
- Subjects
Persian Gulf ,Food hygiene ,food and beverages ,Original Article ,Mercury ,Methyl mercury ,human activities ,humanities ,Canned tuna - Abstract
Due to hygienic risks of mercury residues in food and marine originated supplements, measuring total mercury and methyl mercury contents of canned tuna as a highly consumable marine food product is essential. In this study, 40 canned Tuna fish (from Persian Gulf) were collected in 2015 and then flame atomic absorption spectrometer (FAAS) and thermo gas chromatography mass spectrophotometry were used to measure total mercury and methyl mercury, respectively. The results indicated that the average contents of total mercury and methyl mercury of the canned tunas, with 34.2 and 29.5 ppb decrements compared with 2009's measurement, were 177.4 and 143.7 ppb respectively. The highest concentration of the total mercury was 315.2 while it was 267.9 ppb for methyl mercury. This study showed that the content of the mercury in canned tunas of the Persian Gulf was less than the Maximum Residue Limit (MRL).
- Published
- 2018
15. Doxorubicin‐induced senescence through NF‐κB affected by the age of mouse mesenchymal stem cells.
- Author
-
Bashiri Dezfouli, Ali, Salar‐Amoli, Jamileh, Pourfathollah, Ali Akbar, Yazdi, Mina, Nikougoftar‐Zarif, Mahin, Khosravi, Mohammad, and Hassan, Jalal
- Subjects
- *
CANCER treatment , *HIGH performance liquid chromatography , *CELL cycle , *CELL analysis , *CELLULAR aging , *TELOMERES , *MESENCHYMAL stem cells - Abstract
The senescence is proposed as a defense mechanism against many anticancer drugs. This complication is marked by differences in cell appearance and inner structures underlying the impairment in function. In this experiment, doxorubicin‐induced senescence was assessed in mesenchymal stem cells (MSCs) isolated from the bone marrow of different‐aged Balb/c mice (1, 8, and 16 months old). In addition, doxorubicin kinetics in culture medium were investigated to compare the drug absorption rate by different‐aged MSCs. Several methods were exerted including Sandwich ELISA for NF‐κB activation, propidium iodide staining for cell cycle analysis, Flow‐fluorescent in‐situ hybridization (Flow‐FISH) assay for telomere length measurement, and specific staining for evaluation of β‐galactosidase. Determination of doxorubicin in a medium was performed by high‐performance liquid chromatography technique. Following doxorubicin exposure, cells underwent substantial telomere shortening, cell cycle arresting in G2 phase, and increased β‐galactosidase activity. Interestingly, the enhanced level of NF‐κB was observed in all age groups. The highest and lowest sensitivity to telomere shortening attributed to 1‐ and 8‐month‐old MSCs, respectively. In consistent with Flow‐FISH results, the β‐galactosidase activity was higher in young‐aged MSCs after treatment. Statistical analysis indicated a correlation between the reduction of telomere length and cessation in G2 phase. Regarding the obtained kinetics equations, the rate of doxorubicin absorption by all aged MSCs followed the same trend. In conclusion, the changing of some elements involved in doxorubicin‐induced senescence can be affected by the age of the cells significantly in young MSCs than two other age groups. Hereupon, these changing patterns can open new insights to develop anticancer therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful Development.
- Author
-
Bashiri Dezfouli, Ali, Yazdi, Mina, Pockley, Alan Graham, Khosravi, Mohammad, Kobold, Sebastian, Wagner, Ernst, and Multhoff, Gabriele
- Subjects
- *
KILLER cells , *CHIMERIC antigen receptors , *CELL death , *CYTOTOXIC T cells , *ANTIBODY-dependent cell cytotoxicity , *CYTOKINE release syndrome , *TUMOR antigens - Abstract
In recent years, cell-based immunotherapies have demonstrated promising results in the treatment of cancer. Chimeric antigen receptors (CARs) arm effector cells with a weapon for targeting tumor antigens, licensing engineered cells to recognize and kill cancer cells. The quality of the CAR-antigen interaction strongly depends on the selected tumor antigen and its expression density on cancer cells. CD19 CAR-engineered T cells approved by the Food and Drug Administration have been most frequently applied in the treatment of hematological malignancies. Clinical challenges in their application primarily include cytokine release syndrome, neurological symptoms, severe inflammatory responses, and/or other off-target effects most likely mediated by cytotoxic T cells. As a consequence, there remains a significant medical need for more potent technology platforms leveraging cell-based approaches with enhanced safety profiles. A promising population that has been advanced is the natural killer (NK) cell, which can also be engineered with CARs. NK cells which belong to the innate arm of the immune system recognize and kill virally infected cells as well as (stressed) cancer cells in a major histocompatibility complex I independent manner. NK cells play an important role in the host's immune defense against cancer due to their specialized lytic mechanisms which include death receptor (i.e., Fas)/death receptor ligand (i.e., Fas ligand) and granzyme B/perforin-mediated apoptosis, and antibody-dependent cellular cytotoxicity, as well as their immunoregulatory potential via cytokine/chemokine release. To develop and implement a highly effective CAR NK cell-based therapy with low side effects, the following three principles which are specifically addressed in this review have to be considered: unique target selection, well-designed CAR, and optimized gene delivery. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
17. The profile of circulating extracellular vesicles depending on the age of the donor potentially drives the rejuvenation or senescence fate of hematopoietic stem cells.
- Author
-
Abbasi Sourki, Parvaneh, Pourfathollah, Ali Akbar, Kaviani, Saeed, Soufi Zomorrod, Mina, Ajami, Mansoureh, Wollenberg, Barbara, Multhoff, Gabriele, and Bashiri Dezfouli, Ali
- Subjects
- *
EXTRACELLULAR vesicles , *AGE groups , *HEMATOPOIETIC stem cells , *BLOOD donors , *EXOSOMES - Abstract
Blood donor age has become a major concern due to the age-associated variations in the content and concentration of circulating extracellular nano-sized vesicles (EVs), including exosomes. These EVs mirror the state of their parental cells and transfer it to the recipient cells via biological messengers such as microRNAs (miRNAs, miRs). Since the behavior of hematopoietic stem cells (HSCs) is potentially affected by the miRs of plasma-derived EVs, a better understanding of the content of EVs is important for the safety and efficacy perspectives in blood transfusion medicine. Herein, we investigated whether the plasma-derived EVs of young (18–25 years) and elderly human donors (45–60 years) can deliver "youth" or "aging" signals into human umbilical cord blood (hUCB)-derived HSCs in vitro. The results showed that EVs altered the growth functionality and differentiation of HSCs depending on the age of the donor from which they are derived. EVs of young donors could ameliorate the proliferation and self-renewal potential of HSCs whereas those of aged donors induced senescence-associated differentiation in the target cells, particularly toward the myeloid lineage. These findings were confirmed by flow cytometric analysis of surface markers and microarray profiling of genes related to stemness (e.g., SOX-1, Nanog) and differentiation (e.g., PU-1). The results displayed an up-regulation of miR-29 and miR-96 and a down-regulation of miR-146 in EVs derived from elderly donors. The higher expression of miR-29 and miR-96 contributed to the diminished expression of CDK-6 and CDKN1A (p21), promoting senescence fate via cell growth suppression, while the lower expression of miR-146 positively regulates TRAF-6 expression to accelerate biological aging. Our findings reveal that plasma-derived EVs from young donors can reverse the aging-associated changes in HSCs, while vice versa, the EVs from elderly donors rather promote the senescence process. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. In Vivo Endothelial Cell Gene Silencing by siRNA-LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting.
- Author
-
Yazdi M, Pöhmerer J, Hasanzadeh Kafshgari M, Seidl J, Grau M, Höhn M, Vetter V, Hoch CC, Wollenberg B, Multhoff G, Bashiri Dezfouli A, and Wagner E
- Abstract
Although small-interfering RNAs (siRNAs) are specific silencers for numerous disease-related genes, their clinical applications still require safe and effective means of delivery into target cells. Highly efficient lipid nanoparticles (LNPs) are developed for siRNA delivery, showcasing the advantages of novel pH-responsive lipoamino xenopeptide (XP) carriers. These sequence-defined XPs are assembled by branched lysine linkages between cationizable polar succinoyl tetraethylene pentamine (Stp) units and apolar lipoamino fatty acids (LAFs) at various ratios into bundle or U-shape topologies. Formulation of siRNA-LNPs using LAF
4 -Stp1 XPs as ionizable compounds led to robust cellular uptake, high endosomal escape, and successful in vitro gene silencing activity at an extremely low (150 picogram) siRNA dose. Of significance is the functional in vivo endothelium tropism of siRNA-LNPs with bundle LAF4 -Stp1 XP after intravenous injection into mice, demonstrated by superior knockdown of liver sinusoidal endothelial cell (LSEC)-derived factor VIII (FVIII) and moderate silencing of hepatocyte-derived FVII compared to DLin-MC3-DMA-based LNPs. Optimizing lipid composition following click-modification of siRNA-LNPs with ligand c(RGDfK) efficiently silenced vascular endothelial growth factor receptor-2 (VEGFR-2) in tumor endothelial cells (TECs). The findings shed light on the role of ionizable XPs in the LNP in vivo cell-type functional targeting, laying the groundwork for future therapeutic applications., (© 2024 The Author(s). Small published by Wiley‐VCH GmbH.)- Published
- 2024
- Full Text
- View/download PDF
19. Evaluation of age effects on doxorubicin-induced toxicity in mesenchymal stem cells.
- Author
-
Bashiri Dezfouli A, Pourfathollah AA, Salar-Amoli J, Khosravi M, Nikogoftar-Zarif M, Yazdi M, and Ali-Esfahani T
- Abstract
Background: Doxorubicin, by aggregating in bone marrow, causes genotoxic effects, and thus reduces the repair ability of cells. The present study was conducted as an in vitro evaluation of age effects on the cytotoxicity induced by doxorubicin in mesenchymal stem cells (MSCs). Methods: The MSCs of female BALB/c mice aged 1, 8, and 16 months were separated, characterized, and subsequently evaluated in cellular growth media. After 24 hours, exposure of the MSCs of the 3 groups of mice to doxorubicin (25, 50, 100, 200, 400, 800, 1200 nM) and cytotoxicity were assessed, and the sublethal dose was determined using flow cytometry technique and lactate dehydrogenase (LDH) release assay. Results: The IC50 values determined by flow cytometry for the separated MSCs of 1 young, 8 middle- aged, and 16 old mice were and respectively. Interestingly, the results of these 2 methods in determining cytotoxicity were in agreement, and a concentration of approximately 25 nM was considered to be the shared sublethal dose for different ages. Conclusion: The results indicated that MSCs of middle-aged mice were more resistant to the toxic effects of the drug. Besides, MSCs separated from the old mice were the most sensitive to chemotherapy and its side effects such as disruptions of cell proliferation and viability. These disruptions can be ascribed to the alteration of function and physiological processes with age. Determining proper concentration of doxorubicin drug to destruct cancerous cells based on age and individual sensitivity can minimize the amount of toxicity.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.